Patents by Inventor Matthew Radmer

Matthew Radmer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

Substituted Imidazoquinolines, Imidazopyridines, and Imidazonaphthyridines

Publication number: 20070287724

Abstract: Imidazo-quinoline, -pyridine, and -naphthyridine ring systems (particularly quinolines, tetrahydroquinolines, pyridines, 1,5-naphthyridines, 1,5-tetrahydronaphthyridines) substituted at the 1-position with a cyclic substituent, pharmaceutical compositions containing the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.

Type: Application

Filed: June 17, 2005

Publication date: December 13, 2007

Applicant: 3M INNOVATIVE PROPERTIES COMPANY

Inventors: Doris Stoermer, Joseph Dellaria, David Amos, Bernhard Zimmermann, Luke Dressel, Jason Bonk, Matthew Radmer
Sulfone substituted imidazo ring ethers

Publication number: 20070155767

Abstract: Imidazo ring compounds (e.g., imidazoquinolines, 6,7,8,9-tetrahydroimidazoquinolines, imidazonaphthyridines, and 6,7,8,9-tetrahydroimidazonaphthyridines) with a sulfide-, sulfinyl-, or sulfonyl-containing ether substituent at the 1-position, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.

Type: Application

Filed: December 3, 2004

Publication date: July 5, 2007

Inventors: Matthew Radmer, William Moser, Joan Moseman, Joseph Dellaria
Substituted imidazo ring systems and methods

Publication number: 20070072893

Abstract: Imidazo ring systems substituted at the 1-position, pharmaceutical compositions containing the compounds, inter-mediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.

Type: Application

Filed: November 24, 2004

Publication date: March 29, 2007

Inventors: Larry Krepski, Joseph Dellaria, Daniel Duffy, Matthew Radmer, David Amos
ETHER SUBSTITUTED IMIDAZOPYRIDINES

Publication number: 20060252792

Abstract: Imidazopyridine compounds that contain an ether or thioether functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.

Type: Application

Filed: July 24, 2006

Publication date: November 9, 2006

Inventors: Joseph Dellaria, Kyle Lindstrom, Luke Dressel, Philip Heppner, John Jacobsen, Joan Moseman, William Moser, Matthew Radmer, Doris Stoermer
Pyrazolopyridines and analogs thereof

Publication number: 20060100229

Abstract: Pyrazolopyridin-4-amines, pyrazoloquinolin-4-amines, pyrazolonaphthyridin-4-amines, and 6,7,8,9-tetrahydropyrazoloquinolin-4-amines, pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.

Type: Application

Filed: April 1, 2005

Publication date: May 11, 2006

Inventors: David Hays, Michael Danielson, John Gerster, Shri Niwas, Ryan Prince, Tushar Kshirsagar, Philip Heppner, William Moser, Joan Moseman, Matthew Radmer, Maureen Kavanagh, Sarah Strong, Jason Bonk
Thioether substituted imidazoquinolines

Publication number: 20050209267

Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain thioether functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Type: Application

Filed: May 19, 2005

Publication date: September 22, 2005

Inventors: Joseph Dellaria, Matthew Radmer
Thioether substituted imidazoquinolines

Publication number: 20050209268

Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain thioether functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Type: Application

Filed: May 19, 2005

Publication date: September 22, 2005

Inventors: Joseph Dellaria, Matthew Radmer
Ether substituted imidazopyridines

Publication number: 20050032830

Abstract: Imidazopyridine compounds that contain an ether or thioether functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.

Type: Application

Filed: August 11, 2004

Publication date: February 10, 2005

Inventors: Joseph Dellaria, Kyle Lindstrom, Luke Dressel, Daniel Duffy, Philip Heppner, John Jacobsen, Joan Moseman, William Moser, Matthew Radmer, Doris Stoermer, Bernhard Zimmermann